OREX

Orexigen Therapeutics, Inc.
OREX

Overview Fund Activity
Delisted

OREX was delisted on the 3rd of April, 2018.

Back to rankings

128 hedge funds and large institutions have $431M invested in Orexigen Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 30 reducing their positions, and 21 closing their positions.

Holders
128
Holders Change
-1
Holders Change %
-0.78%
% of All Funds
3.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
52
Reduced
30
Closed
21
Calls
$8.43M
Puts
$10.4M
Net Calls
-$2M
Net Calls Change
-$1.99M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$34.7M
2
SC
2
Samlyn Capital
New York
$9.79M
3
NMC
3
NEA Management Company
Maryland
$15.8M
4
Morgan Stanley
4
Morgan Stanley
New York
$5.34M
5
CC
5
CQS Cayman
Cayman Islands
$7.46M

Top Sellers

1
First Manhattan
1
First Manhattan
New York
$42K
2
Capital Research Global Investors
2
Capital Research Global Investors
California
$33.6M
3
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$0
4
Fidelity International
4
Fidelity International
Bermuda
$4.61M
5
Bank of America
5
Bank of America
North Carolina
$10.6M
Name Market Value Shares Shares
Change 		Shares
Change %
WMSA
151
Weiss Multi-Strategy Advisers
New York
– – – –
PCM
152
Prelude Capital Management
New York
– – – –
3 4 5 6
7